Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
Follow us @OWHealthEditor
RT @jhoronjeff : Thanks @jacqueline_says @OWHealthEditor for including coverage of my hospital gown, but more importantly, for talking with…
RT @MayfieldFund : Thanks to everyone who joined us last week for our inaugural Health Innovator Summit with @awscloud ! Here are some of the…
RT @jacqueline_says : 41% of @startuphealth founder & co-founder attendees were female. Read my interviews with leaders speaking out on #gen…
1 in 3 Americans holds a BCBS insurance card. Here is @BCBSM 's next step in the evolution of provider relationships. https://t.co/8Fo23AH7yK #OWHealth
RT @DaveMarczuk : Rejecting “business as usual” means embracing a new attitude about cost as a strategic #investment , not as an inconvenienc…
RT @MotifConsulting : The state of interoperability and open data for US healthcare is in big transition, and 2020 may be a year to remember…
RT @SyncThinkInc : On Monday, Dr. Ghajar was interviewed by @MartyMakary at the @startuphealth Festival in San Francisco. Watch using the li…
RT @alexwittenberg1 : According to the World Economic Forum's 2020 Global #Risks Report, climate inaction is increasing global risk for busi…
On #OWHealth : Cost is an opportunity for every choice to become a strategic decision, not just another transaction. https://t.co/So1bsiOPBL #CostTransformation
RT @jacqueline_says : 1 in 3 Americans has a @BCBSAssociation insurance card. Read #OWHealth 's @BCBSM interview about how their payment tran…
